The company's patented Fully Enzymatic Synthesis (FES) produces long, high-quality, sequence-specific DNA reliably, affordably, and sustainably, inspired by nature. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology, precision medicine, and emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. With investments from various companies, Molecular Assemblies has a highly experienced executive and scientific team and an expansive intellectual property portfolio.